Fundz

ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs

PRIVATEJul 10, 2023

Company

ReCode Therapeutics

Menlo ParkBiotechnologyHealthcareHealth Care

Description

ReCode Therapeutics, a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs. In this newly created role, Ms. Jefferson will be responsible for the strategic leadership, development, and management of ReCode’s external and employee communications initiatives, including media, investor, and stakeholder engagement

Quick answer

ReCode Therapeutics Appoints Erica Jefferson as Senior Vice President of Corporate Affairs (July 10, 2023). ReCode Therapeutics is based in Menlo Park, California, United States.

What did ReCode Therapeutics announce on July 10, 2023?
ReCode Therapeutics, a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics, announced today the appointment of Erica Jefferson as senior vice president of corporate affairs.
What does ReCode Therapeutics do?
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics.
Where is ReCode Therapeutics based?
ReCode Therapeutics is based in Menlo Park, California, United States.
Which similar companies made leadership changes around the same time?
MBX Biosciences, Inc. (July 10, 2023), EyePoint, Inc. (July 10, 2023), Arbutus (July 11, 2023) and Verastem Oncology (July 11, 2023) also announced leadership changes within 45 days of ReCode Therapeutics.

Source: Fundz verified event record.

Other recent leadership changes in Healthcare and Biotechnology

Executive moves at companies in the same sectors within 45 days, from Fundz verified event records.

Who to call at ReCode Therapeutics, and when

A new leader at ReCode Therapeutics brings new priorities and often new vendors. The first weeks are when they listen.

  • An alert the day ReCode Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at ReCode Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at ReCode Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

ReCode Therapeutics

Location

Menlo Park, California, United States

About

ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment ReCode Therapeutics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

Priya
Senior decision-maker at this company
••••••••@••••••••

See Priya's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for ReCode Therapeutics's next move

Learn about Strategic plan

ReCode Therapeutics changed its leadership. Fundz had it the day it was filed, with the decision-maker at the company attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.